Literature DB >> 21940663

Enhanced store-operated Ca²+ entry and TRPC channel expression in pulmonary arteries of monocrotaline-induced pulmonary hypertensive rats.

Xiao-Ru Liu1, Ming-Fang Zhang, Na Yang, Qing Liu, Rui-Xing Wang, Yuan-Ning Cao, Xiao-Ru Yang, James S K Sham, Mo-Jun Lin.   

Abstract

Pulmonary hypertension (PH) is associated with profound vascular remodeling and alterations in Ca(2+) homeostasis in pulmonary arterial smooth muscle cells (PASMCs). Previous studies show that canonical transient receptor potential (TRPC) genes are upregulated and store-operated Ca(2+) entry (SOCE) is augmented in PASMCs of chronic hypoxic rats and patients of pulmonary arterial hypertension (PAH). Here we further examine the involvement of TRPC and SOCE in PH with a widely used rat model of monocrotaline (MCT)-induced PAH. Rats developed severe PAH, right ventricular hypertrophy, and significant increase in store-operated TRPC1 and TRPC4 mRNA and protein in endothelium-denuded pulmonary arteries (PAs) 3 wk after MCT injection. Contraction of PA and Ca(2+) influx in PASMC evoked by store depletion using cyclopiazonic acid (CPA) were enhanced dramatically, consistent with augmented SOCE in the MCT-treated group. The time course of increase in CPA-induced contraction corresponded to that of TRPC1 expression. Endothelin-1 (ET-1)-induced vasoconstriction was also potentiated in PAs of MCT-treated rats. The response was partially inhibited by SOCE blockers, including Gd(3+), La(3+), and SKF-96365, as well as the general TRPC inhibitor BTP-2, suggesting that TRPC-dependent SOCE was involved. Moreover, the ET-1-induced contraction and Ca(2+) response in the MCT group were more susceptible to the inhibition caused by the various SOCE blockers. Hence, our study shows that MCT-induced PAH is associated with increased TRPC expression and SOCE, which are involved in the enhanced vascular reactivity to ET-1, and support the hypothesis that TRPC-dependent SOCE is an important pathway for the development of PH.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21940663      PMCID: PMC3328901          DOI: 10.1152/ajpcell.00247.2011

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  73 in total

Review 1.  Treatment of pulmonary arterial hypertension.

Authors:  Marc Humbert; Olivier Sitbon; Gérald Simonneau
Journal:  N Engl J Med       Date:  2004-09-30       Impact factor: 91.245

2.  Nifedipine reduces pulmonary pressure and vascular tone during short- but not long-term treatment of pulmonary hypertension in patients with chronic obstructive pulmonary disease.

Authors:  P Agostoni; E Doria; C Galli; G Tamborini; M D Guazzi
Journal:  Am Rev Respir Dis       Date:  1989-01

3.  Acute effects of oxygen, nifedipine, and diltiazem in patients with cystic fibrosis and mild pulmonary hypertension.

Authors:  A Davidson; A Bossuyt; I Dab
Journal:  Pediatr Pulmonol       Date:  1989

4.  Chronic hypoxia-induced upregulation of store-operated and receptor-operated Ca2+ channels in pulmonary arterial smooth muscle cells: a novel mechanism of hypoxic pulmonary hypertension.

Authors:  Mo-Jun Lin; George P H Leung; Wei-Min Zhang; Xiao-Ru Yang; Kay-Pong Yip; Chung-Ming Tse; James S K Sham
Journal:  Circ Res       Date:  2004-07-15       Impact factor: 17.367

5.  Enhanced expression of transient receptor potential channels in idiopathic pulmonary arterial hypertension.

Authors:  Ying Yu; Ivana Fantozzi; Carmelle V Remillard; Judd W Landsberg; Naomi Kunichika; Oleksandr Platoshyn; Donna D Tigno; Patricia A Thistlethwaite; Lewis J Rubin; Jason X-J Yuan
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-09       Impact factor: 11.205

6.  NIP-121 is more effective than nifedipine in acutely reversing chronic pulmonary hypertension.

Authors:  M Oka; K G Morris; I F McMurtry
Journal:  J Appl Physiol (1985)       Date:  1993-09

7.  Overexpression of TRPC1 enhances pulmonary vasoconstriction induced by capacitative Ca2+ entry.

Authors:  Naomi Kunichika; Ying Yu; Carmelle V Remillard; Oleksandr Platoshyn; Shen Zhang; Jason X-J Yuan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2004-06-25       Impact factor: 5.464

8.  Potent inhibition of Ca2+ release-activated Ca2+ channels and T-lymphocyte activation by the pyrazole derivative BTP2.

Authors:  Christof Zitt; Bettina Strauss; Eva C Schwarz; Nicola Spaeth; Georg Rast; Armin Hatzelmann; Markus Hoth
Journal:  J Biol Chem       Date:  2004-01-12       Impact factor: 5.157

Review 9.  Mechanisms and pathology of monocrotaline pulmonary toxicity.

Authors:  D W Wilson; H J Segall; L C Pan; M W Lamé; J E Estep; D Morin
Journal:  Crit Rev Toxicol       Date:  1992       Impact factor: 5.635

Review 10.  Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure.

Authors:  Kurt R Stenmark; Barbara Meyrick; Nazzareno Galie; Wolter J Mooi; Ivan F McMurtry
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-09-11       Impact factor: 5.464

View more
  32 in total

Review 1.  Transient receptor potential channels in the vasculature.

Authors:  Scott Earley; Joseph E Brayden
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

2.  Effects of chronic exposure to cigarette smoke on canonical transient receptor potential expression in rat pulmonary arterial smooth muscle.

Authors:  Jian Wang; Yuqin Chen; Chunyi Lin; Jing Jia; Lichun Tian; Kai Yang; Lei Zhao; Ning Lai; Qian Jiang; Yueqian Sun; Nanshan Zhong; Pixin Ran; Wenju Lu
Journal:  Am J Physiol Cell Physiol       Date:  2013-12-11       Impact factor: 4.249

3.  Chronic hypoxia upregulates pulmonary arterial ASIC1: a novel mechanism of enhanced store-operated Ca2+ entry and receptor-dependent vasoconstriction.

Authors:  Nikki L Jernigan; Lindsay M Herbert; Benjimen R Walker; Thomas C Resta
Journal:  Am J Physiol Cell Physiol       Date:  2011-12-28       Impact factor: 4.249

Review 4.  Molecular pathogenesis and current pathology of pulmonary hypertension.

Authors:  Vinicio A de Jesus Perez
Journal:  Heart Fail Rev       Date:  2016-05       Impact factor: 4.214

5.  Sodium tanshinone IIA sulfonate inhibits canonical transient receptor potential expression in pulmonary arterial smooth muscle from pulmonary hypertensive rats.

Authors:  Jian Wang; Qian Jiang; Limei Wan; Kai Yang; Yi Zhang; Yuqin Chen; Elizabeth Wang; Ning Lai; Lei Zhao; Hua Jiang; Yueqian Sun; Nanshan Zhong; Pixin Ran; Wenju Lu
Journal:  Am J Respir Cell Mol Biol       Date:  2012-10-11       Impact factor: 6.914

6.  Sildenafil inhibits hypoxia-induced transient receptor potential canonical protein expression in pulmonary arterial smooth muscle via cGMP-PKG-PPARγ axis.

Authors:  Jian Wang; Kai Yang; Lei Xu; Yi Zhang; Ning Lai; Hua Jiang; Yajie Zhang; Nanshan Zhong; Pixin Ran; Wenju Lu
Journal:  Am J Respir Cell Mol Biol       Date:  2013-08       Impact factor: 6.914

Review 7.  Vascular remodeling in pulmonary hypertension.

Authors:  Larissa A Shimoda; Steven S Laurie
Journal:  J Mol Med (Berl)       Date:  2013-01-19       Impact factor: 4.599

Review 8.  Lung Circulation.

Authors:  Karthik Suresh; Larissa A Shimoda
Journal:  Compr Physiol       Date:  2016-03-15       Impact factor: 9.090

9.  Down-regulation of TRPM8 in pulmonary arteries of pulmonary hypertensive rats.

Authors:  Xiao-Ru Liu; Qing Liu; Gai-Ying Chen; Ying Hu; James S K Sham; Mo-Jun Lin
Journal:  Cell Physiol Biochem       Date:  2013-06-17

10.  Classical transient receptor potential 1 and 6 contribute to hypoxic pulmonary hypertension through differential regulation of pulmonary vascular functions.

Authors:  Yang Xia; Xiao-Ru Yang; Zhenzhen Fu; Omkar Paudel; Joel Abramowitz; Lutz Birnbaumer; James S K Sham
Journal:  Hypertension       Date:  2013-10-21       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.